Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCA
NCT03617302Phase 1Completed
- Start
- Nov 2018
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 1, randomised trial (2 arms). Primary endpoints: Change in Carotid Artery Compliance at 2 hours, Change in Carotid Augmentation Index at 2 hours and 1 more. Started Nov 2018; status: completed.
Beyond the preview
Go deeper on NCT03617302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03617302.